Subscribe To
An old dog with a new trick… ellodi’s apt-1011 promises eoe patients a convenient and potent treatment alternative
spherix Global Insights finds doctors have yet to define where APT-1011 will sit in the treatment path ...
August 15, 2023, 7:40 pm
Breaking into a saturated relapsing remitting multiple sclerosis market: where should developers focus?
According to spherix Global Insights, U.S. neurologists are largely satisfied with current treatment ch...
August 1, 2023, 4:02 pm
First-to-market edge for apellis’s syfovre in geographic atrophy diminished in the face of an unexpected safety signal
Prospects for Syfovre uptake and trust in Apellis take a plunge following reports of intraocular inflammation, according to ...
July 28, 2023, 4:26 pm